All eyes were on the trade deal signed between American President Donald Trump and Malaysian Prime Minister Anwar Ibrahim last year, but what seemingly went under the radar was the implications the deal has in the field of medicine. Part of the deal included Malaysia “accepting prior marketing authorisation by the FDA as sufficient evidence” that medical devices and pharmaceutical products from the U.S. can be used in our country. We speak with Brook K. Baker, Professor of Law Emeritus at Northeastern University, about what this actually means for Malaysia and our healthcare system. 

Image Credit: Shutterstock

Produced by: Lim Sue Ann

Presented by: Lim Sue Ann

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  health policy,  international,  Law/Activism,  government

Tags:  US-Malaysia trade deal,  the bigger picture,  health & living,  medical devices,  drugs,  imports,  tariffs,  npra,  drug regulation,